Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Jeffrey J. Kraws

Jeffrey J. Kraws is recorded as Board Member at Theriva Biologics, Inc. (TOVX). Theriva Biologics, Inc. reported in an 8-K filed August 4, 2026 that Jeffrey J. Kraws was appointed Director, effective August 3, 2026. Theriva Biologics, Inc. reported in an 8-K filed September 4, 2025 that Jeffrey J. Kraws was appointed Director, effective August 29, 2025. Theriva Biologics, Inc. reported in an 8-K filed November 1, 2024 that Jeffrey J. Kraws was appointed director, effective October 31, 2024. Equibles holds 4 filed executive changes naming Jeffrey J. Kraws; each is listed under recent activity with its source filing. The proxy statement of Flyte Aviation, Inc. reports total compensation of $517,522 for Jeffrey J. Kraws in fiscal 2019, including a base salary of $345,425. Disclosed compensation is on record for 2 fiscal years.

“The following four (4) individuals were elected as directors, to serve until the Company’s next annual meeting of stockholders and until their respective successors have been duly elected and qualified with the following votes:”
Theriva Biologics, Inc. Form 8-K, filed August 4, 2026 · Read the filing
“The following four (4) individuals were elected as directors, to serve until the Company's next annual meeting of stockholders and until their respective successors have been duly elected and qualified with the following votes:”
Theriva Biologics, Inc. Form 8-K, filed September 4, 2025 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Flyte Aviation, Inc.

Other people whose current roles at this company are on record from its filings.

Leadership on record at Theriva Biologics, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2019 Flyte Aviation, Inc. (VJET) $345,425 $517,522
2018 Flyte Aviation, Inc. (VJET) $228,000 $8,914,269

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.